COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

NCT06627530 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Darolutamide Oral Tablet
DRUG: leuprorelin

Sponsor

Brazilian Clinical Research Institute

Collaborators

[object Object]